A biomarker is, according to the US National Institutes of Health, "a characteristic that is objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention."
Biomarkers make take the form of cellular characteristics, metabolites (e.g. sugars, lipids and hormones), molecular variations, or physical features (e.g., clinical symptoms) and are assessed accordingly, via measurement, annotation, documents, and images.
Increasingly, the discovery of novel biomarkers is closely associated with the advances in molecular biology techniques that can be accessed through analysis of DNA, RNA or proteins.
We can discriminate four main types of molecular biomarkers:
• Genomic biomarkers: Based on the analysis of DNA (deoxyribonucleic acid) profiles, especially the analysis of SNPs (single nucleotide polymorphisms), i.e. identification of punctual variations in genomic DNA.
• Transcriptomic biomarkers: Base on the analysis of RNA expression profiles.
• Proteomic biomarkers: Base on the analysis of the protein profiles.
• Metabolomic biomarkers: Base on the analysis of metabolites (metabolites are the intermediates and products of metabolism).
Commercializing biomarkers is the path that a biomarker could be used in therapeutic or diagnostic. In this report mainly covers consumables, services, software of this market.
Scope of the Report:
In the last several years, global market of Commercializing Biomarkers in Therapeutic and Diagnostic Applications developed rapidly, with an average growth rate of 8.49%. In 2015, the consumables revenue growth rate was about 8.5%, the services revenue growth rate was nearly 8.6%, and the consumables revenue growth rate was the highest among the Commercializing Biomarkers in Therapeutic and Diagnostic Applications Industry.
North America is the largest consumer of Commercializing Biomarkers, with the sales market share nearly 42%.
The second place is Europe, following North America with the sales market share of 31%. Japan and China is also the important market, with the total sales marker share of 18.6%.
The worldwide market for Commercializing Biomarkers in Therapeutic and Diagnostic Applications is expected to grow at a CAGR of roughly 6.1% over the next five years, will reach 24400 million US$ in 2024, from 17200 million US$ in 2019, according to a new WMR study.
This report focuses on the Commercializing Biomarkers in Therapeutic and Diagnostic Applications in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Roche
Dako (Agilent Technologies)
Merck
BD
Abbott
Genesys Biolabs (20/20GeneSystems)
Affymetrix
Agendia
ALMAC
Arrayit
Biocartic
BG Medicine
KEGG EXPRESSION Database
Thermo Fisher
BGI
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Consumables
Services
Software
Market Segment by Applications, can be divided into
Oncology
Cardiology
Neurology
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Commercializing Biomarkers in Therapeutic and Diagnostic Applications product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Commercializing Biomarkers in Therapeutic and Diagnostic Applications, with price, sales, revenue and global market share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications in 2017 and 2018.
Chapter 3, the Commercializing Biomarkers in Therapeutic and Diagnostic Applications competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Commercializing Biomarkers in Therapeutic and Diagnostic Applications breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Commercializing Biomarkers in Therapeutic and Diagnostic Applications market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Commercializing Biomarkers in Therapeutic and Diagnostic Applications sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Introduction
1.2 Market Analysis by Type
1.2.1 Consumables
1.2.2 Services
1.2.3 Software
1.3 Market Analysis by Applications
1.3.1 Oncology
1.3.2 Cardiology
1.3.3 Neurology
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Roche
2.1.1 Business Overview
2.1.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Roche Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Dako (Agilent Technologies)
2.2.1 Business Overview
2.2.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Dako (Agilent Technologies) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Merck
2.3.1 Business Overview
2.3.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Merck Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 BD
2.4.1 Business Overview
2.4.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 BD Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Abbott
2.5.1 Business Overview
2.5.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Abbott Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Genesys Biolabs (20/20GeneSystems)
2.6.1 Business Overview
2.6.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Affymetrix
2.7.1 Business Overview
2.7.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Affymetrix Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Agendia
2.8.1 Business Overview
2.8.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Agendia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 ALMAC
2.9.1 Business Overview
2.9.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 ALMAC Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Arrayit
2.10.1 Business Overview
2.10.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Arrayit Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 Biocartic
2.11.1 Business Overview
2.11.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Biocartic Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.12 BG Medicine
2.12.1 Business Overview
2.12.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 BG Medicine Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.13 KEGG EXPRESSION Database
2.13.1 Business Overview
2.13.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 KEGG EXPRESSION Database Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.14 Thermo Fisher
2.14.1 Business Overview
2.14.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Thermo Fisher Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.15 BGI
2.15.1 Business Overview
2.15.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 BGI Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Manufacturer Market Share in 2018
3.3.2 Top 6 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Analysis by Regions
4.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Market Share by Regions
4.1.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Market Share by Regions (2014-2019)
4.1.2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Market Share by Regions (2014-2019)
4.2 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
4.3 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
4.5 South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
5 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Country
5.1 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Market Share by Country
5.1.1 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Market Share by Country (2014-2019)
5.1.2 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Market Share by Country (2014-2019)
5.2 United States Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
5.3 Canada Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
5.4 Mexico Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
6 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Country
6.1 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Market Share by Country
6.1.1 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Market Share by Country (2014-2019)
6.1.2 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Market Share by Country (2014-2019)
6.2 Germany Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
6.3 UK Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
6.4 France Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
6.5 Russia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
6.6 Italy Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
7 Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Country
7.1 Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Market Share by Country (2014-2019)
7.2 China Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
7.3 Japan Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
7.4 Korea Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
7.5 India Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
8 South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Country
8.1 South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Market Share by Country
8.1.1 South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Market Share by Country (2014-2019)
8.1.2 South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Market Share by Country (2014-2019)
8.2 Brazil Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
8.3 Argentina Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
8.4 Colombia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
9 Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Countries
9.1 Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
9.3 Turkey Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
9.4 Egypt Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
9.5 Nigeria Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
9.6 South Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
10 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Segment by Type
10.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Market Share by Type (2014-2019)
10.1.2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Market Share by Type (2014-2019)
10.2 Consumables Sales Growth and Price
10.2.1 Global Consumables Sales Growth (2014-2019)
10.2.2 Global Consumables Price (2014-2019)
10.3 Services Sales Growth and Price
10.3.1 Global Services Sales Growth (2014-2019)
10.3.2 Global Services Price (2014-2019)
10.4 Software Sales Growth and Price
10.4.1 Global Software Sales Growth (2014-2019)
10.4.2 Global Software Price (2014-2019)
11 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Segment by Application
11.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Application (2014-2019)
11.2 Oncology Sales Growth (2014-2019)
11.3 Cardiology Sales Growth (2014-2019)
11.4 Neurology Sales Growth (2014-2019)
11.5 Other Sales Growth (2014-2019)
12 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast (2019-2024)
12.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Growth Rate (2019-2024)
12.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast by Regions (2019-2024)
12.2.1 North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast (2019-2024)
12.2.2 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast (2019-2024)
12.2.3 Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast (2019-2024)
12.2.4 South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast (2019-2024)
12.2.5 Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast (2019-2024)
12.3 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast by Type (2019-2024)
12.3.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Forecast by Type (2019-2024)
12.3.2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share Forecast by Type (2019-2024)
12.4 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast by Application (2019-2024)
12.4.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Forecast by Application (2019-2024)
12.4.2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Picture
Table Product Specifications of Commercializing Biomarkers in Therapeutic and Diagnostic Applications
Figure Global Sales Market Share of Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Types in 2018
Table Commercializing Biomarkers in Therapeutic and Diagnostic Applications Types for Major Manufacturers
Figure Consumables Picture
Figure Services Picture
Figure Software Picture
Figure Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Applications in 2018
Figure Oncology Picture
Figure Cardiology Picture
Figure Neurology Picture
Figure Other Picture
Figure United States Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2014-2024)
Figure France Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2014-2024)
Figure UK Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2014-2024)
Figure China Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2014-2024)
Figure India Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue (Value) and Growth Rate (2014-2024)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
Table Roche Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Dako (Agilent Technologies) Basic Information, Manufacturing Base and Competitors
Table Dako (Agilent Technologies) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
Table Dako (Agilent Technologies) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
Table Merck Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table BD Basic Information, Manufacturing Base and Competitors
Table BD Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
Table BD Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Abbott Basic Information, Manufacturing Base and Competitors
Table Abbott Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
Table Abbott Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Genesys Biolabs (20/20GeneSystems) Basic Information, Manufacturing Base and Competitors
Table Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
Table Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Affymetrix Basic Information, Manufacturing Base and Competitors
Table Affymetrix Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
Table Affymetrix Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Agendia Basic Information, Manufacturing Base and Competitors
Table Agendia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
Table Agendia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table ALMAC Basic Information, Manufacturing Base and Competitors
Table ALMAC Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
Table ALMAC Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Arrayit Basic Information, Manufacturing Base and Competitors
Table Arrayit Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
Table Arrayit Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Biocartic Basic Information, Manufacturing Base and Competitors
Table Biocartic Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
Table Biocartic Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table BG Medicine Basic Information, Manufacturing Base and Competitors
Table BG Medicine Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
Table BG Medicine Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table KEGG EXPRESSION Database Basic Information, Manufacturing Base and Competitors
Table KEGG EXPRESSION Database Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
Table KEGG EXPRESSION Database Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Thermo Fisher Basic Information, Manufacturing Base and Competitors
Table Thermo Fisher Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
Table Thermo Fisher Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table BGI Basic Information, Manufacturing Base and Competitors
Table BGI Commercializing Biomarkers in Therapeutic and Diagnostic Applications Type and Applications
Table BGI Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Manufacturer (2017-2018)
Figure Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Manufacturer in 2017
Figure Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Manufacturer in 2018
Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Manufacturer (2017-2018)
Figure Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Manufacturer in 2017
Figure Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Manufacturer in 2018
Figure Top 3 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Manufacturer (Revenue) Market Share in 2018
Figure Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
Figure Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Growth Rate (2014-2019)
Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Regions (2014-2019)
Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Regions (2014-2019)
Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Regions (2014-2019)
Figure Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Regions in 2014
Figure Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Regions in 2018
Figure North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
Figure Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
Figure South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
Figure North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Growth Rate (2014-2019)
Table North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Countries (2014-2019)
Table North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Countries (2014-2019)
Figure North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Countries in 2014
Figure North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Countries in 2018
Table North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Countries (2014-2019)
Table North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Countries (2014-2019)
Figure North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Countries in 2014
Figure North America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Countries in 2018
Figure United States Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
Figure Canada Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
Figure Mexico Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
Figure Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Growth Rate (2014-2019)
Table Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Countries (2014-2019)
Table Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Countries (2014-2019)
Table Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Countries (2014-2019)
Figure Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Countries in 2017
Figure Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Countries in 2018
Figure Germany Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
Figure UK Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
Figure France Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
Figure Russia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
Figure Italy Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Countries (2014-2019)
Table Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Countries 2018
Table Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Countries (2014-2019)
Figure Asia-Pacific Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Countries 2018
Figure China Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
Figure Japan Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
Figure Korea Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
Figure India Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
Figure Southeast Asia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
Figure South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Growth Rate (2014-2019)
Table South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Countries (2014-2019)
Table South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Countries (2014-2019)
Figure South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Countries in 2018
Table South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Countries (2014-2019)
Table South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Countries (2014-2019)
Figure South America Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Countries in 2018
Figure Brazil Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
Figure Argentina Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
Figure Colombia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Countries (2014-2019)
Table Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Countries in 2018
Table Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Countries (2014-2019)
Table Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Countries in 2014
Figure Middle East and Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Countries in 2018
Figure Saudi Arabia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
Figure UAE Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
Figure Egypt Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
Figure Nigeria Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
Figure South Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales and Growth Rate (2014-2019)
Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Type (2014-2019)
Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Share by Type (2014-2019)
Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Type (2014-2019)
Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Share by Type (2014-2019)
Figure Global Consumables Sales Growth (2014-2019)
Figure Global Consumables Price (2014-2019)
Figure Global Services Sales Growth (2014-2019)
Figure Global Services Price (2014-2019)
Figure Global Software Sales Growth (2014-2019)
Figure Global Software Price (2014-2019)
Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Application (2014-2019)
Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Share by Application (2014-2019)
Figure Global Cardiology Sales Growth (2014-2019)
Figure Global Neurology Sales Growth (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue and Growth Rate (2019-2024)
Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Forecast by Regions (2019-2024)
Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share Forecast by Regions (2019-2024)
Figure North America Sales Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast (2019-2024)
Figure Europe Sales Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast (2019-2024)
Figure Asia-Pacific Sales Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast (2019-2024)
Figure South America Sales Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast (2019-2024)
Figure Middle East and Africa Sales Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast (2019-2024)
Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Forecast by Type (2019-2024)
Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share Forecast by Type (2019-2024)
Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Forecast by Application (2019-2024)
Table Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
Request Sample 
Request Discount 
Inquire Before Buy
